These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25819184)

  • 21. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioresorbable Vascular Scaffolds for Coronary Revascularization.
    Kereiakes DJ; Onuma Y; Serruys PW; Stone GW
    Circulation; 2016 Jul; 134(2):168-82. PubMed ID: 27400899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 25. Stop adding metal layers: Will bioabsorbable scaffolds become the gold standard for late in-stent restenosis and neo-atherosclerosis?
    Kilic ID; Konstantinidis N; Pighi M; Mattesini A; Di Mario C
    Cardiovasc Revasc Med; 2015 Mar; 16(2):124-6. PubMed ID: 25130791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition.
    Attizzani GF; Capodanno D; Ohno Y; Tamburino C
    J Am Coll Cardiol; 2014 Apr; 63(14):1355-67. PubMed ID: 24530675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coregistered intravascular ultrasound and optical coherence tomography imaging during implantation of a bioresorbable vascular scaffold.
    Brown AJ; McCormick LM; Hoole SP; West NE
    JACC Cardiovasc Interv; 2013 Jul; 6(7):e41-2. PubMed ID: 23866193
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.
    Gomez-Lara J; Brugaletta S; Farooq V; van Geuns RJ; De Bruyne B; Windecker S; McClean D; Thuesen L; Dudek D; Koolen J; Whitbourn R; Smits PC; Chevalier B; Morel MA; Dorange C; Veldhof S; Rapoza R; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2011 Jul; 4(7):789-99. PubMed ID: 21777888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.
    Koizumi T; Fitzgerald PJ; Honda Y; Ellis SG; Kent K; Martin SL; Brown CL; Masud AR; Patterson JB; Greenberg J; Friedman M; Uchida T; Stone GW
    Cardiovasc Revasc Med; 2010; 11(3):140-8. PubMed ID: 20599163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application.
    Farooq V; Onuma Y; Radu M; Okamura T; Gomez-Lara J; Brugaletta S; Gogas BD; van Geuns RJ; Regar E; Schultz C; Windecker S; Lefèvre T; Brueren BR; Powers J; Perkins LL; Rapoza RJ; Virmani R; García-García HM; Serruys PW
    EuroIntervention; 2011 Jul; 7(3):386-99. PubMed ID: 21729842
    [No Abstract]   [Full Text] [Related]  

  • 32. Hybrid Strategy for Long Diffuse Coronary Lesion.
    Basavarajaiah S; Qadir M
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1518-1521. PubMed ID: 26298227
    [No Abstract]   [Full Text] [Related]  

  • 33. Head-to-head comparison of a drug-free early programmed dismantling polylactic acid bioresorbable scaffold and a metallic stent in the porcine coronary artery: six-month angiography and optical coherence tomographic follow-up study.
    Durand E; Sharkawi T; Leclerc G; Raveleau M; van der Leest M; Vert M; Lafont A
    Circ Cardiovasc Interv; 2014 Feb; 7(1):70-9. PubMed ID: 24368820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Everolimus-eluting bioresorbable vascular scaffold implantation in Kawasaki disease: serial OCT observation.
    Vogiatzi G; Toutouzas K; Karanasos A; Synetos A; Latsios G; Tsiamis E; Tousoulis D
    Hellenic J Cardiol; 2018; 59(6):358-359. PubMed ID: 29307692
    [No Abstract]   [Full Text] [Related]  

  • 35. Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis.
    Kim JS; Afari ME; Ha J; Tellez A; Milewski K; Conditt G; Cheng Y; Hua Yi G; Kaluza GL; Granada JF
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):292-8. PubMed ID: 24022066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follow-up evaluation of magnesium bioresorbable stent with computed tomography.
    Pozo-Osinalde E; Gonzalo N; Salinas P
    J Cardiovasc Comput Tomogr; 2020; 14(5):e75-e77. PubMed ID: 31088738
    [No Abstract]   [Full Text] [Related]  

  • 38. Coronary bifurcation lesions: Some questions need an answer to make bioresorbable vascular scaffold technology more "coronary bifurcation-friendly".
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Jul; 215():80-3. PubMed ID: 27111164
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries.
    Waksman R; Pakala R; Kuchulakanti PK; Baffour R; Hellinga D; Seabron R; Tio FO; Wittchow E; Hartwig S; Harder C; Rohde R; Heublein B; Andreae A; Waldmann KH; Haverich A
    Catheter Cardiovasc Interv; 2006 Oct; 68(4):607-17; discussion 618-9. PubMed ID: 16969879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simplifying the double kissing (DK) crush with the use of bioresorbable scaffolds.
    Panoulas VF; Sato K; Miyazaki T; Kawamoto H; Latib A; Colombo A
    Int J Cardiol; 2015 Oct; 196():139-42. PubMed ID: 26093528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.